Evaluation of human trial feeding effect of red ginseng, hawthorn and cassia seed tablets on blood lipid lowering and health care function

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055118

Enrollment

Unknown

Registered

2022-01-01

Start date

2022-03-01

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Interventions

Control group:Placebo

Hyperlipidemia group:Red ginseng, hawthorn and cassia seed tablets

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18-65 years. 2. Under normal diet, blood lipid levels after 12-14 hours of fasting were detected, serum total cholesterol (TC) was 5.18-6.21 mmol/L, and serum triglyceride (TG) was 1.70-2.25 mmol/L, which can be used as candidates for auxiliary lowering of blood lipids. 3. Those who obtained informed consent and volunteered to participate in the experiment.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients, allergic constitution or allergic to this test sample. 2. Combined with serious diseases such as heart, liver, kidney and hematopoietic system, mental patients. 3. Those who have taken lipid-lowering drugs in the past two weeks, which affects the judgment of the results. 4. Patients with hyperlipidemia. 5. Those who did not eat the test samples as prescribed, or had incomplete data, which affected the judgment of efficacy or safety.

Design outcomes

Primary

Measure	Time frame
4 items of blood lipids;	—

Countries

China

Contacts

Public ContactYang Yi

kangaoi@kaotg.com+86 18622281699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026